ALZN
Price
$2.46
Change
+$0.02 (+0.82%)
Updated
Aug 29, 03:46 PM (EDT)
Capitalization
7.63M
AURX
Price
$1.63
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
76.17M
Interact to see
Advertisement

ALZN vs AURX

Header iconALZN vs AURX Comparison
Open Charts ALZN vs AURXBanner chart's image
Alzamend Neuro
Price$2.46
Change+$0.02 (+0.82%)
Volume$100
Capitalization7.63M
Nuo Therapeutics
Price$1.63
Change-$0.00 (-0.00%)
Volume$100
Capitalization76.17M
ALZN vs AURX Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. AURX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Buy and AURX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ALZN: $2.43 vs. AURX: $1.63)
Brand notoriety: ALZN and AURX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 18% vs. AURX: 0%
Market capitalization -- ALZN: $7.63M vs. AURX: $76.17M
ALZN [@Biotechnology] is valued at $7.63M. AURX’s [@Biotechnology] market capitalization is $76.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileAURX’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • AURX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALZN and AURX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 6 TA indicator(s) are bullish while AURX’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 6 bullish, 2 bearish.
  • AURX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than AURX.

Price Growth

ALZN (@Biotechnology) experienced а +3.40% price change this week, while AURX (@Biotechnology) price change was -5.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.15%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.12%.

Industries' Descriptions

@Biotechnology (-1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURX($76.2M) has a higher market cap than ALZN($7.63M). AURX YTD gains are higher at: 16.186 vs. ALZN (-76.724). AURX has higher annual earnings (EBITDA): -2.48M vs. ALZN (-4.16M). ALZN has more cash in the bank: 3.36M vs. AURX (316K). AURX has less debt than ALZN: AURX (132K) vs ALZN (301K). AURX has higher revenues than ALZN: AURX (1.95M) vs ALZN (0).
ALZNAURXALZN / AURX
Capitalization7.63M76.2M10%
EBITDA-4.16M-2.48M168%
Gain YTD-76.72416.186-474%
P/E RatioN/AN/A-
Revenue01.95M-
Total Cash3.36M316K1,063%
Total Debt301K132K228%
FUNDAMENTALS RATINGS
AURX: Fundamental Ratings
AURX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNAURX
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 30 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 2 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADDDF198.874.18
+2.15%
adidas AG
NPRFF0.07N/A
+0.63%
NEPRA FOODS INC.
FLCX1.00N/A
N/A
flooidCX Corp.
COGNY0.55N/A
N/A
COGNA EDUCACAO S A
IGGHY14.80N/A
N/A
IG Group Holdings Plc.

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-1.22%
SRPT - ALZN
49%
Loosely correlated
+1.49%
VRAX - ALZN
46%
Loosely correlated
+3.38%
ASBP - ALZN
43%
Loosely correlated
+4.47%
SNSE - ALZN
41%
Loosely correlated
+4.18%
BPMUF - ALZN
36%
Loosely correlated
N/A
More

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
-0.21%
ALZN - AURX
30%
Poorly correlated
-1.22%
VRAX - AURX
27%
Poorly correlated
+3.38%
NCNA - AURX
26%
Poorly correlated
-1.23%
FENC - AURX
23%
Poorly correlated
-1.88%
QNCX - AURX
22%
Poorly correlated
-1.28%
More